Here are five key notes:
1. Researchers analyzed matched pairs of adult inpatients who underwent elective total hip arthroplasty or total knee arthroplasty.
2. The study sought to determine the effects of I.V. acetaminophen on adverse events, hospital length of stay and overall hospital costs for these procedures.
3. The surgeries were conducted from January 2011 to November 2012 at hospitals participating in the Premier Healthcare Alliance.
4. Patients that received I.V. acetaminophen on the day of surgery were matched to a control patient within the same hospital who did not received it, totaling 22,146 cases and controls.
5. Results showed that overall adverse events were significantly lower with I.V. acetaminophen (24.3 percent) than with controls (26.3 percent), as well as being associated with shorter hospital length of stays and lower average hospital costs.
More articles on orthopedics:
Rate of arthroscopic elbow procedures increases — 5 takeaways
Beebe Healthcare names Joseph DeRanieri executive director of orthopedics: 4 things to know
Inspira Medical Center Woodbury unveils orthopedic unit: 3 points
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
